Stanley T. Crooke, Chairman and CEO at IONIS PHARMACEUTICALS INC (IONS), sold 45,320 shares at $85.25 ($3.8M) on 2019-04-15, disclosed to the SEC on 2019-04-17.
Seasonal sale ($3.8M) by Chairman and CEO — this insider has traded IONS in April in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $85.25 | 10,000 | $853K | 22.2% |
| 2 | $85.25 | 1,000 | $85K | 2.2% |
| 3 | $84.56 | 13,320 | $1.1M | 29.3% |
| 4 | $84.56 | 13,320 | $1.1M | 29.3% |
| 5 | $84.75 | 700 | $59K | 1.5% |
| 6 | $84.75 | 300 |
| $25K |
| 0.7% |
| 7 | $84.75 | 6,680 | $566K | 14.7% |
| Total | $84.76 avg | 45,320 | $3.8M | 100% |
| Filing → |
| IONS | SELL | 2020-12-17 | $2.1M | — | Filing → |
| IONS | SELL | 2020-12-09 | $568K | — | Filing → |
| IONS | SELL | 2020-11-30 | $1.3M | — | Filing → |